Biosimilar is an anti-VEGF therapy for retinal vascular disorders
Study recorded all possible benefits and risks for COVID-19 patients receiving treatment
Potential disease modifying osteoarthritis candidate is phase II ready
Government has placed first order for one million tests
On 26 September, Donald Trump held a lengthy ceremony at the White House to announce his nomination of […]
Amid White House feud, FDA raises vaccine rules that could nix a pre-election COVID shot esagonowsky Tue, 10/06/2020 […]
Just days after buyout notice, AMAG faces FDA push to withdraw premature-birth med Makena kblankenship Tue, 10/06/2020 – […]
Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production kblankenship Tue, 10/06/2020 – 09:06
J&J moving to settle 1,000 talc lawsuits for more than $100M: Bloomberg esagonowsky Tue, 10/06/2020 – 08:38
The hearts of professional athletes adapt to training in a number of ways, including by increasing the number […]